RecruitingNot ApplicableNCT04688411

An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Enrollment

40 participants

Start Date

Sep 28, 2020

Study Type

INTERVENTIONAL

Conditions

Sickle Cell Disease Sickle Beta Zero Thalassemia Sickle B+ Thalassemia Sickle Cell Hemoglobin C

Summary

The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and improve health outcomes in AYA with SCD.

Eligibility

Min Age: 12 YearsMax Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called MED-Go App for people with sickle b+ thalassemia, sickle beta zero thalassemia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years to 21 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.